Management of cardiovascular complications in Klinefelter syndrome patients

Expert Review of Endocrinology & Metabolism
Giacomo AccardoDaniela Pasquali

Abstract

Klinefelter syndrome (KS), also known as 47, XXY, shows increased mortality when compared with mortality rates among the general population. Cardiovascular, hemostatic, metabolic diseases are implicated. Moreover, cardiac congenital anomalies in KS can contribute to the increase in mortality. In this study, we have systematically reviewed the relationships between KS and the cardiovascular system and the management of cardiovascular complication. In summary, patients with KS display increased cardiovascular risk profile, characterized by increased prevalence of metabolic alterations including dyslipidemia, diabetes mellitus (DM), and abnormalities in biomarkers of cardiovascular disease. KS subjects are characterized by subclinical abnormalities in endothelial function and in left ventricular (LV) systolic and diastolic function, which - when associated with chronotropic incompetence - may negatively influence cardiopulmonary performance. Moreover, KS patients appear to be at a higher risk for cardiovascular disease, due to thromboembolic events with high prevalence of recurrent venous ulcers, venous insufficiency, recurrent venous and arterial thromboembolism leading to deep venous thrombosis or pulmonary embolism. Considering...Continue Reading

References

Jan 1, 1987·Pediatric Cardiology·I AdatiaJ Harder
Mar 1, 1985·Journal of Epidemiology and Community Health·W H PriceR de Mey
Dec 1, 1985·Journal of Epidemiology and Community Health·W H PriceR De Mey
Dec 1, 1967·Circulation·I EmeritP Corone
Jan 1, 1968·Guy's Hospital Reports·P E Polani
Dec 19, 1981·Lancet·G R FrickeH U Schweikert
Oct 20, 1994·The New England Journal of Medicine·E P SmithK S Korach
Feb 18, 1999·JAMA : the Journal of the American Medical Association·M S LauerT H Marwick
May 11, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·E C TsaiW Y Fujimoto
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·P A HeineP S Cooke
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·M E JonesE R Simpson
Dec 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Burkhard Lorenz HerrmannMartina Broecker
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Anders BojesenClaus Højbjerg Gravholt
Feb 27, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·K Igawa, K Nishioka
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Laura MaffeiCesare Carani
Jul 21, 2004·Lancet·Fabio LanfrancoEberhard Nieschlag
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Anders BojesenClaus H Gravholt
Oct 6, 2005·The Journal of Clinical Endocrinology and Metabolism·Anthony J SwerdlowUNKNOWN United Kingdom Clinical Cytogenetics Group
Jul 1, 1993·Obesity Research·P MårinP Björntorp
Jan 6, 2006·The Journal of Clinical Endocrinology and Metabolism·Anders BojesenClaus H Gravholt
Feb 1, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·V Di BelloA Balbarini
Mar 16, 2006·JAMA : the Journal of the American Medical Association·Eric L DingSimin Liu
Aug 24, 2006·The Journal of Clinical Endocrinology and Metabolism·C ForestaA Garolla
Apr 7, 2007·Nature Clinical Practice. Urology·Anders Bojesen, Claus H Gravholt
Aug 30, 2007·The Journal of Clinical Endocrinology and Metabolism·Maria A YialamasFrances J Hayes
Oct 6, 2007·Archives of Disease in Childhood·L AksglaedeA Juul
Feb 12, 2008·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·James H SteinUNKNOWN American Society of Echocardiography Carotid Intima-Media Thickness Task Force
May 6, 2008·Urology·Tomomoto IshikawaMasato Fujisawa
Mar 17, 2010·Molecular Human Reproduction·A Di MambroC Foresta
Apr 16, 2010·Molecular Human Reproduction·A F RadicioniA Lenzi
Jan 22, 2011·Acta Paediatrica·Martha Z BardsleyJudith L Ross
Feb 5, 2011·Journal of Endocrinological Investigation·A F RadicioniA Lenzi
Mar 9, 2011·Circulation·Peter H Brubaker, Dalane W Kitzman
Mar 19, 2011·Acta Paediatrica·Anders Bojesen, Claus H Gravholt
Apr 1, 2011·European Journal of Preventive Cardiology·Jean DallongevilleUNKNOWN REACH Registry Investigators

❮ Previous
Next ❯

Citations

Sep 9, 2021·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Stephanie CungShanlee M Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.